COGAIN kick-off presentation

Download Report

Transcript COGAIN kick-off presentation

WP 3: User involvement
Mick Donegan – ACE Centre
http://www.ace-centre.org.uk
COGAIN Kick-Off
5.-6.9.2004
Tampere, Finland
Objectives
Ensure user centred design
 Spread
latest information via network
 Long-term support and training
Tasks 1/2
 T3.1 Identify needs of user groups


Involve both users and organisations in all activities…
…design, development, evaluation
 T3.2 Provide information, training and long-term support


To users and organisations
Provide information to enable well-informed choice to meet individual needs
 T3.3 Usability studies – qualitative and quantitative


Recruit volunteers for controlled tests
Recruit volunteers for long-term evaluation
Deliverables
 D3.1 User requirements report (month 6)
 Including ‘observations on difficulties’
 D3.2 Report on features of different systems and
development needs (month 18)
 D3.2 Reports from user tests and usability studies
(month 18)
Milestones
 M3.1 Agreed list of tasks & criteria shared across network
(month 6)
 M3.2 Information and training package of eye communication
systems and organisations involved (month 15)
Estimated Involvement (first 18 months)
Partner
UTA
ITU
BH
RISOE
TU DRESDEN
POLITO
SU
Tobii
ACE
UoD
DMU
Months
4,5
2
0,5
1,5
0,5
1,5
1
1,5
4,3
0,5
2,5
Uni of Tampere
Uni of Copenhagen
Bispebjerg Hospital
Risoe National Laboratory
Technische Universitaet Dresden
Politechnico de Turino
Siauliu Universtitaes
Tobii Technology
ACE Centre
Uni of Derby
De Montfort Uni
Current Status
 ACE Centre has identified a number of users prepared to
participate

varying disabilities
 ACE Centre ready to invite a range of relevant UK
organisations to be involved

e.g., charities & hospital Units
WP3 is different…




Involvement of users with disabilities
Multi-professional involvement
Need for good communication across all Cogain partners
Need to capitalize on this opportunity to establish those lines
of communication…
examples of tasks related to WP:3…











Establish user membership- ie. Users who will be involved over short or long term
Establish organization membership – relevant organizations from different countries
Assess and equip users
Train and support user membership
Identify needs of users and organizations
Report to other partners - user requirements
Help co-ordinate user representation in Cogain meetings
Provide information to users and organisations
Carry out usability studies – qualitative and quantitative
Liaise with other partners - user response to hardware/software modifications
etc…
To Do ASAP – re WP3 members
 Establish good lines of communication between all WP3
members.
 Agree on potential roles/responsibilities of WP3 members in
relation to:



time funded/logistical issues (eg. travel, equipment, etc.)
Current/potential involvement with users
Current responsibilities/interests/ research/ experience
To agree now - Communication between WP:3 members
 There is an urgent deliverable in 6 months. What is the best
way for WP3 members to communicate, initially?

Videoconference? Telephone conference? Email?
 Does a ‘discussion document’ procedure suit WP3 members?

Could WP3 members give me a key contact email address today, please?
To discuss - all
 Aim - We want to produce a User Requirements Document
that is of practical help to all Cogain members.
 Question – What do you want from the ‘user
requirements’ document?
To Discuss (all) - User Requirements Document
I need to capitalize on the collective experience of Cogain members in relation to user
involvement…
 How many Cogain partners have direct experience of
working with users with disabilities?
 If so, could you pass on any relevant information
To Discuss – User Requirements Document - all
I need to have as comprehensive an awareness of the currently available technology as possible
that is relevant to WP3…
 Which of you are working with eye-control (and similar)
systems?


commercially available
laboratory/trial systems
 If so, could you send me any information relating to the
source/ efficacy systems you are using?
ACE Centre
 Anything else you’d like to discuss?
 Contact person for this WP: Mick Donegan
 Email address: [email protected]